bokomslag Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy
Kropp & själ

Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy

Benjamin Bonavida

Inbunden

2259:-

Funktionen begränsas av dina webbläsarinställningar (t.ex. privat läge).

Uppskattad leveranstid 7-12 arbetsdagar

Fri frakt för medlemmar vid köp för minst 249:-

  • 292 sidor
  • 2018
Tyrosine Kinase Inhibitors as Sensitizing Agents for Chemotherapy, the fourth volume in the Cancer Sensitizing Agents for Chemotherapy Series, focuses on strategic combination therapies that involve a variety of tyrosine kinase inhibitors working together to overcome multi-drug resistance in cancer cells. The book discusses several tyrosine kinase inhibitors that have been used as sensitizing agents, such as EGFR, BCR-ABL, ALK and BRAF. In each chapter, readers will find comprehensive knowledge on the inhibitor and its action, including its biochemical, genetic, and molecular mechanisms' emphases. This book is a valuable source for oncologists, cancer researchers and those interested in applying new sensitizing agents to their research in clinical practice and in trials.
  • Författare: Benjamin Bonavida
  • Format: Inbunden
  • ISBN: 9780128164358
  • Språk: Engelska
  • Antal sidor: 292
  • Utgivningsdatum: 2018-11-29
  • Förlag: Elsevier Science Publishing Co Inc